科学图书馆
-
Five-Year Outcomes of Transcatheter or Surgical Aortic-Valve ReplacementRR Makkar, VH Thourani, the PARTNER 2 Investigators. -
Edoxaban versus Vitamin K Antagonist for Atrial Fibrillation after TAVRNM Van Mieghem, M Unverdorben, the ENVISAGE-TAVI AF Investigators.
-
Thrombotic Versus Bleeding Risk After Transcatheter Aortic Valve Replacement: JACC Review Topic of the WeekA Mangieri, C Montalto, E Poletti et al.
-
2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC) Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM)G Habib, P Lancellotti, MJ Antunes et al.
-
Raising the Evidentiary Bar for Guideline Recommendations for TAVR: JACC Review Topic of the WeekS Kaul.
-
Transcatheter Aortic Valve Replacement During PregnancyR Hodson, E Kirker, J Swanson et al.
-
Why and How to Measure Aortic Valve Calcification in Patients With Aortic StenosisT Pawade, T Sheth, E Guzzetti, MR Dweck et al.
-
Clinical impact of conduction disturbances in transcatheter aortic valve replacement recipients: a systematic review and meta-analysisL Faroux, S Chen, J Rodés-Cabau et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
